Observational studyScientific reports2017

Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib.

Arancha Cebrián et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.